• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环 T 细胞特征与血液恶性肿瘤复发相关的肠型特征有关。

Circulating T cell profiles associate with enterotype signatures underlying hematological malignancy relapses.

机构信息

Université de Paris Cité, INSERM U976, 75010 Paris, France.

Université de Paris Cité, INSERM U976, 75010 Paris, France; Virology Department, AP-HP, Saint-Louis Hospital, 75010 Paris, France.

出版信息

Cell Host Microbe. 2023 Aug 9;31(8):1386-1403.e6. doi: 10.1016/j.chom.2023.06.009. Epub 2023 Jul 17.

DOI:10.1016/j.chom.2023.06.009
PMID:37463582
Abstract

Early administration of azithromycin after allogeneic hematopoietic stem cell transplantation was shown to increase the relapse of hematological malignancies. To determine the impact of azithromycin on the post-transplant gut ecosystem and its influence on relapse, we characterized overtime gut bacteriome, virome, and metabolome of 55 patients treated with azithromycin or a placebo. We describe four enterotypes and the network of associated bacteriophage species and metabolic pathways. One enterotype associates with sustained remission. One taxon from Bacteroides specifically associates with relapse, while two from Bacteroides and Prevotella correlate with complete remission. These taxa are associated with lipid, pentose, and branched-chain amino acid metabolic pathways and several bacteriophage species. Enterotypes and taxa associate with exhausted T cells and the functional status of circulating immune cells. These results illustrate how an antibiotic influences a complex network of gut bacteria, viruses, and metabolites and may promote cancer relapse through modifications of immune cells.

摘要

早期给予异基因造血干细胞移植后的阿奇霉素治疗被证明会增加血液系统恶性肿瘤的复发。为了确定阿奇霉素对移植后肠道生态系统的影响及其对复发的影响,我们对 55 名接受阿奇霉素或安慰剂治疗的患者的肠道细菌组、病毒组和代谢组进行了特征分析。我们描述了四个肠型和相关噬菌体物种和代谢途径的网络。一种肠型与持续缓解相关。一种来自拟杆菌的分类群与复发相关,而两种来自拟杆菌和普雷沃氏菌的分类群与完全缓解相关。这些分类群与脂质、戊糖和支链氨基酸代谢途径以及几种噬菌体物种相关。肠型和分类群与耗竭的 T 细胞和循环免疫细胞的功能状态相关。这些结果说明了抗生素如何影响肠道细菌、病毒和代谢物的复杂网络,并可能通过改变免疫细胞来促进癌症复发。

相似文献

1
Circulating T cell profiles associate with enterotype signatures underlying hematological malignancy relapses.循环 T 细胞特征与血液恶性肿瘤复发相关的肠型特征有关。
Cell Host Microbe. 2023 Aug 9;31(8):1386-1403.e6. doi: 10.1016/j.chom.2023.06.009. Epub 2023 Jul 17.
2
Effect of Azithromycin on Airflow Decline-Free Survival After Allogeneic Hematopoietic Stem Cell Transplant: The ALLOZITHRO Randomized Clinical Trial.阿奇霉素对异基因造血干细胞移植后无气流下降生存期的影响:ALLOZITHRO随机临床试验
JAMA. 2017 Aug 8;318(6):557-566. doi: 10.1001/jama.2017.9938.
3
Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation.阿奇霉素通过破坏异基因干细胞移植后的免疫和代谢网络促进复发。
Blood. 2022 Dec 8;140(23):2500-2513. doi: 10.1182/blood.2022016926.
4
Prognostic factors of second hematopoietic allogeneic stem cell transplantation among hematological malignancy patients relapsed after first hematopoietic stem cell transplantation: A single center study.首次造血干细胞移植后复发的血液病患者进行第二次造血异体干细胞移植的预后因素:一项单中心研究。
Front Immunol. 2023 Jan 4;13:1066748. doi: 10.3389/fimmu.2022.1066748. eCollection 2022.
5
TNFR2 blockade of regulatory T cells unleashes an antitumor immune response after hematopoietic stem-cell transplantation.阻断调节性 T 细胞的 TNF-R2 可在造血干细胞移植后引发抗肿瘤免疫反应。
J Immunother Cancer. 2022 Apr;10(4). doi: 10.1136/jitc-2021-003508.
6
[Analysis of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies: A Single-center Study].[血液系统恶性肿瘤患者异基因造血干细胞移植后复发情况分析:一项单中心研究]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022 Aug;30(4):1238-1243. doi: 10.19746/j.cnki.issn.1009-2137.2022.04.042.
7
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.异基因反应性作为血液系统恶性肿瘤治疗的治疗原则。非清髓性预处理的异基因造血细胞移植的临床和免疫学方面的研究。
Dan Med Bull. 2007 May;54(2):112-39.
8
Comparison of clinical outcomes between unrelated single umbilical cord blood and "ex-vivo" T-cell depleted haploidentical transplantation in children with hematological malignancies.比较非亲缘单份脐带血与“体外”T 细胞去除的单倍体相合移植治疗血液系统恶性肿瘤患儿的临床结局。
World J Pediatr. 2021 Dec;17(6):609-618. doi: 10.1007/s12519-021-00461-w. Epub 2021 Sep 30.
9
Azithromycin does not increase hematologic relapse in pediatric hematopoietic cell transplant recipients.阿奇霉素不会增加小儿造血细胞移植受者的血液学复发率。
Bone Marrow Transplant. 2022 Oct;57(10):1589-1591. doi: 10.1038/s41409-022-01746-y. Epub 2022 Jul 1.
10
Azithromycin Use and Increased Cancer Risk among Patients with Bronchiolitis Obliterans after Hematopoietic Cell Transplantation.造血细胞移植后闭塞性细支气管炎患者使用阿奇霉素与癌症风险增加
Biol Blood Marrow Transplant. 2020 Feb;26(2):392-400. doi: 10.1016/j.bbmt.2019.10.025. Epub 2019 Nov 1.

引用本文的文献

1
Metabolism in hematology: Technological advances open new perspectives on disease biology and treatment.血液学中的新陈代谢:技术进步为疾病生物学和治疗开辟了新的视角。
Hemasphere. 2025 May 19;9(5):e70134. doi: 10.1002/hem3.70134. eCollection 2025 May.
2
Unravelling neutropenic enterocolitis: insights from gut microbiota, and intestinal barrier analyses.解析中性粒细胞减少性小肠结肠炎:来自肠道微生物群和肠道屏障分析的见解
Exp Hematol Oncol. 2025 May 16;14(1):74. doi: 10.1186/s40164-025-00661-4.
3
Novel regulators of GVHD revealed through microbiome and metabolome patterns across distinct intestinal regions.
通过不同肠道区域的微生物组和代谢组模式揭示的移植物抗宿主病新调节因子。
Blood. 2025 Jun 5;145(23):2774-2787. doi: 10.1182/blood.2024025924.
4
The intestinal microbiota and cellular therapy: implications for impact and mechanisms.肠道微生物群和细胞治疗:影响和机制的意义。
Blood. 2024 Oct 10;144(15):1557-1569. doi: 10.1182/blood.2024024219.
5
Metabolic instruction of the graft-versus-leukemia immunity.移植物抗白血病免疫的代谢指令。
Front Immunol. 2024 Mar 4;15:1347492. doi: 10.3389/fimmu.2024.1347492. eCollection 2024.